Over the last 4 years, the ACO & Emerging Healthcare Delivery Coalition has continued to grow as a result of the opportunities to hear about innovations in accountable care organizations (ACOs) and to network with a diverse group of people, said Anthony Slonim, MD, DrPH, president and CEO of Renown Health and chair of the ACO Coalition.
Over the last 4 years, the ACO & Emerging Healthcare Delivery Coalition has continued to grow as a result of the opportunities to hear about innovations in accountable care organizations (ACOs) and to network with a diverse group of people, said Anthony Slonim, MD, DrPH, president and CEO of Renown Health and chair of the ACO Coalition.
Transcript
How has the ACO Coalition grown and evolved since its inception?
The ACO Coalition continues to grow. We have more members and more diverse members than we've ever had over the course of our 4 years. And I think that's a testament to what people get when they come to a meeting. They get an opportunity to hear cutting edge work that's innovative. They get to not only understand what people are doing at the research level, but how they apply it in their own ACO. And the networking opportunities are incomparable to anywhere else in the places where you go to get networking.
It's just an amazing place to be and a great opportunity to come together a couple of times a year. And to keep that momentum going, even in between the live meetings.
The ACO Coalition, while it continues to grow in size and diversity, is a place where we like to showcase innovation. So if you have innovative ideas about how you're running your ACO, or how you are advancing the health of your community or the population that you serve, bring it on. We'd love to hear about it and share it with our members.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
GLP-1 Receptor Agonists Reduce Adverse Cardiovascular Outcomes, Improve Survival
August 2nd 2025Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival in those with coronary plaque and after ST-elevation myocardial infarction.
Read More